Overview

p>Citicoline (CDP choline, cytidine diphosphate-choline) is an intermediary in the synthesis of phosphatidylcholine, which is a critical component of healthy cell membranes. As a naturally-occurring compound, citicoline is vital to the well-being of cells and is particularly renowned for its potential to enhance cognitive function.

Its use as a supplement has been linked to a plethora of nootropic effects:

Citicoline has repeatedly been shown to be capable of protecting neuronal cells, including retinal cells essential for vision, from injury and degeneration.1 Though the precise mechanism behind its neuroprotective activity is still being investigated, key steps in the process have been proposed:2

Increasing dopamine levelsp>Furthermore, citicoline has demonstrated a capacity to stimulate neurotransmitters, i.e., dopamine, which plays a critical role in visual pathways.3Citicoline Benefits & Uses for Visionp>Citicoline has widely been discussed and even implemented as a potential treatment for various eye conditions, particularly glaucoma and amblyopia, which often result as a consequence of neurodegeneration.4 Its success as a medical drug to improve eye health for 5 decades has led to its use in recent years as a natural supplement to counteract the development of vision loss before it even gets started.5 One such supplement, Cognizin, has been touted as ranking among the upper echelon of citicoline variations due to its patenting, stability, and clinical backing.

Citicoline has been shown to help rescue damaged retinal cells when used in a stack with lithium.6

In this clinical investigation, 11 glaucoma patients were given 500 milligrams of citicoline twice daily for 2 periods of 14 days. The visual evoked potentials (VEP) were significantly improved based on reduced latency and increased amplitude after treatment.

In this clinical investigation, glaucoma patients were given citicoline either orally at 1600 mg or intramuscularly at 1000 mg everyday for 2 periods lasting 60 days each. Retinal function and neural conduction were reported to have improved in both groups.

The researchers concluded that “these results suggest potential neuroprotective effects of citicoline in the glaucomatous disease.”11

In this randomized, double-blind, placebo-controlled investigation, 50 patients with amblyopia were given 1000 mg of intramuscular citicoline or a placebo every day for 6 months. Visual acuity was significantly improved in the citicoline group compared to the placebo, and no adverse side effects were observed.

In this randomized, placebo-controlled investigation, 40 patients with open angle glaucoma were given either a placebo or 1000 mg of intramuscular citicoline every day for 2 periods of 60 days. Citicoline treatment induced significant improvements in visual evoked potential (VEP) and pattern-electroretinograms (PERGs) compared to the placebo, with further improvements noted after the second round of treatment.

The researchers concluded that “citicoline may induce an improvement of the retinal and of the visual pathway function in patients with glaucoma.”13

In this investigation, 10 patients with amblyopia were given 1000 mg of intramuscular Neuroton® citicoline every day for 15 days. On average, treatment improved visual acuity (VA), contrast sensitivity (CS), and visual evoked potentials (VEPs) in both normal and amblyopic eyes.

The researchers concluded that “treating adult amblyopes with CDP-choline has the effect of improving their VA, CS and VEPs.”14

In this placebo-controlled investigation, 56 patients with open angle glaucoma (OAG) were treated with either 3 drops of OMK1® topical citicoline or a beta-blocker control every day for 4 months. The citicoline group was shown to have a significant increase in pattern electroretinogram (PERG) amplitudes and decrease in visual evoked potentials (VEP) latency compared to the control, which suggests improvements in vision.

The researchers concluded that “citicoline in OAG eyes induces an enhancement of the retinal bioelectrical responses… [and] improvement of the bioelectrical activity of the visual cortex.”15

In this clinical study, 45 children with amblyopia between the ages of 5 to 9 years were treated with 500 mg of citicoline, the same amount of citicoline in conjunction with occlusion, or just occlusion every day for 10 days. The trial was repeated again after 6 months. Citicoline was found to improve overall visual acuity and enhance occlusion treatment.

The researchers concluded that “CDP-choline enhances the effect of part-time occlusion.”16

In this randomized, controlled trial, 84 patients with amblyopia between the ages of 4 to 13 years were treated with either patching alone or patching with citicoline (250 mg for patients under 5 years and 500 for those over 5 years) every day for 6 months. Significantly greater improvement in visual acuity was reported in patients treated with both citicoline and patching than patching alone.

The researchers concluded that “improvement in visual acuity with citicoline plus patching was significantly more than that with patching alone.”17

Dosage for Vision

Dosage for Vision

Available Forms

Tablets, c

Available Forms

i>

Intramuscular injection

Eye drops

Supplements in Review SaysSupplements in Review Says

pt;">Citicoline 250 – 500 mg for vision.

Citicoline seems to be an excellent vision supplement. We highly recommend citicoline as a vision enhancer to reduce the risk of developing as well as combat current neurodegenerative eye conditions. No serious adverse side effects or drug interactions have been reported.

Try patented citicoline supplements with scientific backing. Years of medical use have produced many varieties of citicoline treatments. We recommend starting with a patented and clinically supported pill, such as Cognizin®, at 250 – 500 mg per day.